Practice Update - ESC Congress 2017

3 / 24

PracticeUpdate is guided by a world-renowned Editorial and
Advisory Board that represents community practitioners and
academic specialists with cross-disciplinary expertise.
Editor-in-Chief Douglas Zipes MD
Associate Editors Joerg Herrmann MD, Benjamin Scirica MD
Advisory Board Deepak Bhatt MDMPH FACC FAHA FSCAI FESC,
Peter Libby MD, Paul Thompson MD,
James Udelson MD, Ronald Victor MD,
Gary Webb MD,
Clyde Yancy MDMScMACCFAHAMACP
Editorial Contributors Ashish Aggarwal MD, Samer Ajam MD,
Jason Garlie MD, John Garner MD
PracticeUpdate® is a registered trademark
of Elsevier Inc. 2017 Elsevier Inc. All rights reserved.
ABOUT
For a complete listing of disclosures for each board member
and editorial contributor, please refer to their profile on
PracticeUpdate.com
PracticeUpdate’s mission is to help medical professionals navigate
the vast array of available literature and focus on the most critical
information for their patients and practice.
PracticeUpdate Conference Series is a collection of key
research from leading international conferences, reviewed by
thePracticeUpdate editorial and advisory board, made available
in print format. These news highlights and more are also available
online at PracticeUpdate.com
PracticeUpdate and the PracticeUpdate Conference Series
are commercially supported by advertising, sponsorship, and
educational grants. Individual access to PracticeUpdate.com is
free. Premium content is available to any user who registers with
the site.
While PracticeUpdate is a commercially-sponsored product, it
maintains the highest level of academic rigour, objectivity, and
fair balance associated with all Elsevier products. No editorial
content is influenced in any way by commercial sponsors or
content contributors.
DISCLAIMER
The PracticeUpdate Conference Seriesprovides highlights of key
international conferences for specialist medical professionals. The
ideas and opinions expressed in this publication do not necessarily
reflect those of the Publisher. Elsevier will not assume responsibility
for damages, loss, or claims of any kind arising from or related to the
informationcontained in thispublication, includinganyclaimsrelated
to the products, drugs, or services mentioned herein. Because of
rapid advances in the medical sciences, in particular, independent
verification of diagnoses and drug dosages should be made. Please
consult the full current Product Information before prescribing any
medication mentioned in this publication.
Although all advertising material is expected to conform to
ethical (medical) standards, inclusion in this publication does not
constitute a guarantee or endorsement of the quality or value
of such product or of the claims made of it by its manufacturer.
This ESC Congress 2017 PracticeUpdate Conference Series is
distributed with the support of A. Menarini Australia. The editorial
content herein is independently produced by Elsevier with no
involvement by A. Menarini Australia.
SALES
Fleur Gill
Linnea Mitchell-Taverner
PRODUCTION
Content was originally published on PracticeUpdate.com
Production of this issue was executed by:
Editorial Manager Anne Neilson
Editorial Project Manager Carolyn Ng
DesignerJana Sokolovskaja
ISSN 2208-150X (Print) • ISSN 2208-1518 (Online)
ELSEVIER AUSTRALIA ABN 70 001 002 357
475 Victoria Avenue Chatswood NSW 2067 Australia
Locked Bag 7500 Chatswood DC NSW 2067
Printed in Australia.
EMC081701
4 The Interleukin-1β Inhibitor
Canakinumab Cuts Cardiovascular
Disease and Lung Cancer Risk by
Reducing Inflammation – CANTOS Trial
6 Ibuprofen Is Associated with a Rise
in Blood Pressure in Patients with
Arthritis and Cardiovascular Risk –
PRECISION-ABPM Trial
7 Ablation of Atrial Fibrillation Improves
Quality of Life More than Drugs –
CAPTAF Trial
8 Renal Denervation Lowers Blood
Pressure in Hypertensive Patients Not
Taking Antihypertensive Medication –
SPYRAL HTN-OFF MED Trial
8 Oxygen Therapy Does Not Improve
Survival in Patients With Symptoms of
MI – DETO2X-AMI
10 Catheter Ablation Improves Outcomes
in Patients With Heart Failure and
Atrial Fibrillation – CASTLE-AF Trial
11 Apixaban Lowers Stroke Risk in
Patients Undergoing Cardioversion for
Atrial Fibrillation – EMANATE Trial
12 Two Results of the PURE Study May
Be Game Changers in Heart Disease
Prevention
14 Risk Factor-Driven Upstream Atrial
Fibrillation Therapy Improves Sinus
Rhythm Maintenance
14 Women Are Less Likely Than Men to
Receive Recommended Statin Doses
16 Underweight is Associated with
Highest Mortality and Costs After
Cardiac Catheterization
18 Rivaroxaban + Aspirin Is Shown to
Improve Outcomes in Patients With
Stable Cardiovascular Disease –
COMPASS Trial
19 The Gender Gap in Death from Acute
Myocardial Infarction is Closing,
Particularly in Women Younger than
Age 60
20 Screening for Vascular Disease Saves
More Lives at Lower Cost than Cancer
Screening – VIVA Trial
22Anacetrapib Reduces Risk of Serious
Cardiovascular Events in High-Risk
Patients on Statins – REVEAL Trial
© ESC Congress 2017 – European Society of Cardiology
4 12
CONTENTS
ESC Congress 2017 • PRACTICEUPDATE CONFERENCE SERIES 3